Mohan Natesan

Dr. Mohan Natesan


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1998 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
DBDavid R. Baselt
David R. Baselt
GLGil U. Lee
Gil U. Lee
MNMohan Natesan
Mohan Natesan
SMSteven W. Metzger
Steven W. Metzger
PSPaul E. Sheehan
Paul E. Sheehan
RCRichard J. Colton
Richard J. Colton

15 April 1996 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MNMohan Natesan
Mohan Natesan
ZRZ Razi-Wolf
Z Razi-Wolf
HRH Reiser
H Reiser
We have examined the capacity of murine B7-1 and B7-2 to costimulate the production of IL-4 by murine CD4+ T lymphocytes. Cloned and freshly isolated T cells were incubated with the anti-CD3 mAb 145-2C11 in the presence of Chinese hamster ovary (CHO) cells that stably express murine B7-1 and B7-2 at comparable levels. IL-4 protein levels were measured in culture supernatants by the CT.4S bioassay, and levels of IL-4 mRNA were determined by semiquantitative reverse transcription-PCR. Both B7-1- and B7-2-transfected CHO cells, but not CHO control transfectants, were able to costimulate IL-4 production. Similarly, both B7-1 and B7-2 could up-regulate IFN-γ mRNA levels. Cell fractionation experiments on freshly isolated CD4+ T lymphocytes revealed that the costimulatory potential of B7-1 and B7-2 for IL-4 production was restricted to CD44high T cells, i.e., the subpopulation that contains recently activated and memory cells. CD44low, naive CD4+ T lymphocytes, could only be induced to produce IL-4 by repeated stimulation with B7 transfectants. In summary, we have not detected qualitative differences in the capacities of murine B7-1 and B7-2 to induce IL-4 production. The results of our experiments, therefore, argue against the recent hypothesis that precursor Th cells are directed toward the Th2 phenotype by B7-2 and toward the Th1 phenotype by B7-1.

1 December 2000 in Analytical Biochemistry
Verified
Journal Article
Closed access
GLGil U. Lee
Gil U. Lee
SMSteven Metzger
Steven Metzger
MNMohan Natesan
Mohan Natesan
CYCarolyn Yanavich
Carolyn Yanavich
YDYves F. Dufrêne
Yves F. Dufrêne

1 August 2016 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
PDF file
MNMohan Natesan
Mohan Natesan
SJStig M. Jensen
Stig M. Jensen
SKSarah L. Keasey
Sarah L. Keasey
TKTeddy Kamata
Teddy Kamata
AKAna I. Kuehne
Ana I. Kuehne
RURobert G. Ulrich
Robert G. Ulrich
A detailed understanding of serological immune responses to Ebola and Marburg virus infections will facilitate the development of effective diagnostic methods, therapeutics, and vaccines. We examined antibodies from Ebola or Marburg survivors 1 to 14 years after recovery from disease, by using a microarray that displayed recombinant nucleoprotein (NP), viral protein 40 (VP40), envelope glycoprotein (GP), and inactivated whole virions from six species of filoviruses. All three outbreak cohorts exhibited significant antibody responses to antigens from the original infecting species and a pattern of additional filoviruses that varied by outbreak. NP was the most cross-reactive antigen, while GP was the most specific. Antibodies from survivors of infections by Marburg marburgvirus (MARV) species were least cross-reactive, while those from survivors of infections by Sudan virus (SUDV) species exhibited the highest cross-reactivity. Based on results revealed by the protein microarray, persistent levels of antibodies to GP, NP, and VP40 were maintained for up to 14 years after infection, and survival of infection caused by one species imparted cross-reactive antibody responses to other filoviruses.

1 September 1999 in Journal of Vacuum Science & Technology A
Verified
Journal Article
Closed access
SMSteven W. Metzger
Steven W. Metzger
MNMohan Natesan
Mohan Natesan
CYCarolyn Yanavich
Carolyn Yanavich
JSJames Schneider
James Schneider
GLGil U Lee
Gil U Lee
The high cost and harsh processing conditions associated with microfabricated biosensors demand a new approach to receptor immobilization. We have grafted biotin labeled, 3400 molecular weight poly(ethylene glycol) (PEG) to silicon surfaces to produce a dense PEG monolayer with functionally active biotin. These surfaces have been activated with antibodies through the strong streptavidin-biotin interaction by simply incubating the surfaces with antibody-streptavidin conjugates. The stability of the biotinylated PEG monolayers produces a sensing element that can be regenerated by removal of the streptavidin conjugate and stored in a dry state for extended periods of time.

Verified
Journal Article
Open access
PDF file
MNMohan Natesan
Mohan Natesan
RURobert G. Ulrich
Robert G. Ulrich
Protein microarrays are powerful tools that are widely used in systems biology research. For infectious diseases, proteome microarrays assembled from proteins of pathogens will play an increasingly important role in discovery of diagnostic markers, vaccines, and therapeutics. Distinct formats of protein microarrays have been developed for different applications, including abundance-based and function-based methods. Depending on the application, design issues should be considered, such as the need for multiplexing and label or label free detection methods. New developments, challenges, and future demands in infectious disease research will impact the application of protein microarrays for discovery and validation of biomarkers.